
Professor, Director, Airways Clinical Research Center, Baylor College of Medicine, Chief, PCCM, BT Hosp. Editor-in-Chief, Respiratory Medicine #resmedjournal
Texas, USA
Joined August 2017
- Tweets1.2K
- Following833
- Followers1.3K
- Likes1.6K
Nicola A. Hanania retweeted
The Canadian Act on COPD National Steering Group (NSG) has developed "My COPD Checklist" which empowers patients to have meaningful discussions with their health care providers. To download the Checklist: copdcanada.info/my-copd-chec…
Nicola A. Hanania retweeted
Defining disease stability in #COPD: evidence from phase 3 clinical trials
doi.org/10.1093/ajrccm/aamag… @atscommunity
Another glimmer of hope for our COPD patients!
Tozorakimab to Prevent COPD Exacerbations | New England Journal of Medicine nejm.org/doi/full/10.1056/NE…
@CHESTAirways @BCMLungInst @BCM_Lung
Nicola A. Hanania retweeted
There's growing optimism in our ability to treat #COPD — and with good reason.
Nicola Hanania, MD, discusses late-breaking data showing dupilumab's protection of lung function after exacerbations. Watch the full #CHEST2025 interview here: hubs.li/Q03PC5j10
Nicola A. Hanania retweeted
Severe asthma care is evolving. Geoffrey Chupp, MD, moderates a discussion with Jacqueline Ross, MD; Michael Wechsler, MD, MSc; and Nicola Hanania, MD, MS on TSLP inhibition.
Watch: hubs.li/Q04rSM4r0
Nicola A. Hanania retweeted
The ATS is extremely disappointed that FDA has chosen to approve 11 new flavored nicotine pouch products. The evidence is clear that flavored tobacco products, including tobacco pouches , lure kids in tobacco addiction. FDA should reconsider.
Symptom burden to characterise, predict, and prevent asthma attacks: a... sciencedirect.com/science/ar…
@BCMLungInst @BCM_Lung @CHESTAirways
Nicola A. Hanania retweeted
💪🏽👇🏼🎉
FDA has approved the first mRNA-based seasonal influenza vaccine for adults 50 years and older. The vaccine is indicated for the prevention of influenza disease caused by influenza A subtypes and influenza B strains represented in the vaccine.
Approval includes:
➡️Traditional Approval for adults 50–64 years based on clinical efficacy
➡️Accelerated Approval for adults 65+ based on immune responses, with a required post-approval study to confirm clinical benefit
Nicola A. Hanania retweeted
You got to give it to Israeli politicians - they really want to make work of ICC prosecutors easy. Here’s Israel’s Defense(?) Secretary Katz bragging about purposeful,systematic & indiscriminate destruction & expulsion of villages & communities
#צריךלהשוות
Nicola A. Hanania retweeted
Our urgent call in BMJ is out: >3400 signed letter calling on Word Medical Associations to STOP THEIR SILENCE. Dr. Abu Safiya is imprisoned by Israel >18 months with no charges. Solitary confinement. Beatings. His life threatened. This must End. 🧵
bmj.com/content/394/bmj-2026…
Nicola A. Hanania retweeted
Join us for an urgent Webinar about Dr. Safiya, Friday July 10th, at 12PM - I will be among the speakers - physicians should be rewarded for taking care of their patients not detained and tortured for it cugh.org/events/webinar-emer…
Nicola A. Hanania retweeted
A warm welcome to the newest members of our Department of Medicine faculty! We are excited to have them join our community and look forward to the knowledge, collaboration, and fresh perspectives they'll bring! 🌟
Nicola A. Hanania retweeted
From our fellowship director: you may have faculty or trainees with ties to Venezuela, here’s an opportunity to show solidarity: Donate to
the Venezuelan American Medical Association (VAMA) earthquake relief fund
#HelpVAMA
gofundme.com/f/help-vama?att…
Nicola A. Hanania retweeted
Respiratory mortality in chronic obstructive pulmonary disease: fixed ratio versus lower limit of normal in smokers
doi.org/10.1093/ajrccm/aamag…
@suryapbhatt
@meilan_han
@atscommunity
Congratulations to all our BCM students and best of luck colleagues 👍@bcmhouston















